Sponsor Dossier
Amicus Therapeutics
Sponsor Dossier for Amicus Therapeutics. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
About
Amicus Therapeutics is an Australian Private Company with ABN 87621776476, registered in NSW. The entity is active and registered for GST.
Portfolio
Amicus Therapeutics has three brands on the ARTG, all of which are indexable. All three brands have Product Information on file. One brand is PBS-listed, one has PBAC outcome records, and all three brands have AusPAR records. Notable brands include GALAFOLD, OPFOLDA, and POMBILITI.
Therapeutic focus
— Rare Disease: 1 brand — Endocrinology: 1 brand — Oncology: 1 brand
PBS footprint
One brand in the Amicus Therapeutics portfolio is PBS-listed, with the latest PBS schedule date being 1 May 2026.
Regulatory activity
The latest PBAC outcome for Amicus Therapeutics is dated 1 March 2025, covering one brand. The latest AusPAR is dated 10 February 2025, with three brands holding AusPAR records.